Alerts will be sent to your verified email
Verify Email
SHUKRAPHAR
|
Shukra Pharma
|
IOL Chem & Pharma
|
Panacea Biotec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 8.9 % | 36.5 % |
|
5yr average Equity Multiplier
|
2.02 | 1.42 | 0.36 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.99 | 0.41 |
|
5yr Avg Net Profit Margin
|
13.41 % | 6.28 % | 26.1 % |
|
Price to Book
|
37.46 | 1.38 | 2.8 |
|
P/E
|
206.11 | 20.84 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | 37.81 Days | -170.26 Days |
|
Inventory Days
|
40.87 Days | 65.55 Days | 120.03 Days |
|
Days Receivable
|
186.38 Days | 86.45 Days | 42.2 Days |
|
Days Payable
|
342.97 Days | 100.1 Days | 325.14 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 15.8 | 2.7 |
|
5yr Avg ROCE
|
14.63 % | 12.63 % | -2.79 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 10.64 % | -3.85 % |
|
5 yr average Debt to Equity
|
0.23 | 0.04 | -0.69 |
|
5yr CAGR Net Profit
|
119.04 % | -9.63 % | -43.68 % |
|
5yr Average Return on Assets
|
8.68 % | 6.27 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 52.62 % | 72.48 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.79 % | 8.93 % | -1.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shukra Pharma
|
IOL Chem & Pharma
|
Panacea Biotec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|